Annual Accounts Receivable:
$46.76M+$30.14M(+181.33%)Summary
- As of today, TARS annual accounts receivable is $46.76 million, with the most recent change of +$30.14 million (+181.33%) on December 31, 2024.
- TARS annual accounts receivable is now at all-time high.
Performance
TARS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Accounts Receivable:
$72.62M+$14.29M(+24.49%)Summary
- As of today, TARS quarterly accounts receivable is $72.62 million, with the most recent change of +$14.29 million (+24.49%) on September 30, 2025.
- Over the past year, TARS quarterly accounts receivable has increased by +$43.46 million (+149.05%).
- TARS quarterly accounts receivable is now at all-time high.
Performance
TARS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TARS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +181.3% | +149.1% |
| 3Y3 Years | - | +10000.0% |
| 5Y5 Years | - | - |
TARS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | at high | >+9999.0% |
| 5Y | 5-Year | at high | >+9999.0% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
TARS Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $72.62M(+24.5%) |
| Jun 2025 | - | $58.33M(-6.6%) |
| Mar 2025 | - | $62.43M(+33.5%) |
| Dec 2024 | $46.76M(+181.3%) | $46.76M(+60.4%) |
| Sep 2024 | - | $29.16M(-1.3%) |
| Jun 2024 | - | $29.53M(-1.2%) |
| Mar 2024 | - | $29.89M(+79.8%) |
| Dec 2023 | $16.62M | $16.62M(+210.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.36M(+114.5%) |
| Mar 2023 | - | $2.50M(>+9900.0%) |
| Dec 2022 | $0.00 | - |
| Sep 2022 | - | $17.00K(0.0%) |
| Jun 2022 | - | $17.00K(0.0%) |
| Mar 2022 | - | $17.00K(-99.9%) |
| Jun 2021 | - | $20.00M(-37.9%) |
| Mar 2021 | - | $32.20M |
FAQ
- What is Tarsus Pharmaceuticals, Inc. annual accounts receivable?
- What is the all-time high annual accounts receivable for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Tarsus Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all-time high quarterly accounts receivable for Tarsus Pharmaceuticals, Inc.?
- What is Tarsus Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Tarsus Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of TARS is $46.76M
What is the all-time high annual accounts receivable for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high annual accounts receivable is $46.76M
What is Tarsus Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, TARS annual accounts receivable has changed by +$30.14M (+181.33%)
What is Tarsus Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of TARS is $72.62M
What is the all-time high quarterly accounts receivable for Tarsus Pharmaceuticals, Inc.?
Tarsus Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $72.62M
What is Tarsus Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, TARS quarterly accounts receivable has changed by +$43.46M (+149.05%)